Rebosura, Baby Girl .
HRN: 23-05-30 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/01/2023
AMPICILLIN 250MG (VIAL)
06/01/2023
06/07/2023
IV
145
Q12
Sepsis Neonatarum
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes